MétaCan
Menu
Back to cohort
Record W2967703731 · doi:10.1093/jncics/pkz049

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions

2019· article· en· W2967703731 on OpenAlexaffabout
Ryan J.O. Dowling, Joseph A. Sparano, Pamela J. Goodwin, François‐Clément Bidard, David W. Cescon, Sarat Chandarlapaty, Joseph O. Deasy, Mitch Dowsett, Robert J. Gray, N. Lynn Henry, Funda Meric‐Bernstam, Jane Perlmutter, George W. Sledge, Mangesh A. Thorat, Scott V. Bratman, Lisa A. Carey, Martin C. Chang, Angela DeMichele, Marguerite Ennis, Katarzyna J. Jerzak, Larissa A. Korde, Ana Elisa Lohmann, Eleftherios P. Mamounas, Wendy R. Parulekar, Meredith M. Regan, Daniel Schramek, Vuk Stambolic, Timothy J. Whelan, Antonio C. Wolff, James R. Woodgett, Kevin Kalinsky, Daniel F. Hayes

Bibliographic record

VenueJNCI Cancer Spectrum · 2019
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBreast Cancer Treatment Studies
Canadian institutionsMcMaster UniversityQueen's UniversityStatistics CanadaHealth Sciences CentreLunenfeld-Tanenbaum Research InstituteJuravinski Cancer CentreSunnybrook Health Science CentreSinai Health SystemPrincess Margaret Cancer CentreUniversity of TorontoUniversity Health Network
Fundersnot available
KeywordsMedicineImmunosurveillanceBreast cancerDiseaseClinical trialEstrogen receptorObservational studyOncologyEstrogenCancerCancer recurrenceInternal medicineIntensive care medicine

Abstract

fetched live from OpenAlex

Late disease recurrence (more than 5 years after initial diagnosis) represents a clinical challenge in the treatment and management of estrogen receptor-positive breast cancer (BC). An international workshop was convened in Toronto, Canada, in February 2018 to review the current understanding of late recurrence and to identify critical issues that require future study. The underlying biological causes of late recurrence are complex, with the processes governing cancer cell dormancy, including immunosurveillance, cell proliferation, angiogenesis, and cellular stemness, being integral to disease progression. These critical processes are described herein as well as their role in influencing risk of recurrence. Moreover, observational and interventional clinical trials are proposed, with a focus on methods to identify patients at risk of recurrence and possible strategies to combat this in patients with estrogen receptor-positive BC. Because the problem of late BC recurrence of great importance, recent advances in disease detection and patient monitoring should be incorporated into novel clinical trials to evaluate approaches to enhance patient management. Indeed, future research on these issues is planned and will offer new options for effective late recurrence treatment and prevention strategies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.008
metaresearch head score (Gemma)0.005
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.115
Threshold uncertainty score0.229

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0080.005
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.002
Science and technology studies0.0010.002
Scholarly communication0.0030.001
Open science0.0020.002
Research integrity0.0030.006
Insufficient payload (model declined to judge)0.0070.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.051
GPT teacher head0.330
Teacher spread0.279 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations17
Published2019
Admission routes2
Has abstractyes

Explore more

Same venueJNCI Cancer SpectrumSame topicBreast Cancer Treatment StudiesFrench-language works237,207